BeOne Medicines (ONC) Price to Earnings (2016 - 2026)

BeOne Medicines (ONC) Price to Earnings (2016 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Oculis Holding AG	66,801.52 Bn	66,801.23 Bn	-	-31.17 Bn
2	Nanobiotix	1,935.05 Bn	1,934.98 Bn	-	-70,009.43
3	Akari Therapeutics	1,021.31 Bn	1,021.31 Bn	-	-34,771.56
4	BeOne Medicines	467.89 Bn	463.10 Bn	1.35 Bn	912.03
5	Vertex Pharmaceuticals	122.95 Bn	115.70 Bn	2.59 Bn	28.34
6	Regeneron Pharmaceuticals	70.19 Bn	61.44 Bn	3.31 Bn	15.87
7	Belite Bio	63.46 Bn	63.46 Bn	-	373.32 Bn
8	Argenx Se	55.64 Bn	50.45 Bn	1.41 Bn	32.44
9	Alnylam Pharmaceuticals	37.67 Bn	34.66 Bn	959.66 Mn	69.26
10	Revolution Medicines	37.48 Bn	37.48 Bn	-	-27.32

Download Data